SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after achieving its first-ever quarterly profit amidst strong delivery growth, sparking fervent community discussion about a potential short squeeze and its long-term undervaluation given its unique battery swap technology and new chip innovations.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is highly volatile amid conflicting reports surrounding the Strait of Hormuz, ranging from US intelligence indications of potential Iranian mining to a retracted government claim of naval escorts. This geopolitical uncertainty, coupled with political statements about the Iran conflict nearing its end, is fueling community debate over market manipulation and global oil supply stability.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending with soaring investor enthusiasm, driven by its recently secured EPA, UK, and EU regulatory clearances for its ultra-pure graphene and strong anticipation of major commercial contracts and a NASDAQ uplisting. The community widely views the company as a potential leader for the "graphene age," poised to revolutionize diverse sectors from defense to AI data centers.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending following news of a $30M acceleration program for its Tanbreez Heavy Rare Earth project, fueling community debate about potential resource expansion and the upcoming Bankable Feasibility Study. Bulls foresee a significant re-rating in the strategically vital rare earth sector, while others eye the stock cautiously given past volatility and skepticism regarding prior economic assessments.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is seeing extreme volatility, with community discussion centered on conflicting reports about the Strait of Hormuz
Aquickly deleted government claim of a navy escort was followed by intelligence suggesting Iran is deploying mines, leading to sharp market swings and widespread accusations of manipulation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending following recent analyst upgrades and positive sentiment from its Barclays conference, where management highlighted AI integration and a clear strategy for BetterHelp's turnaround, with the community actively debating its perceived undervaluation and potential for a short squeeze as the turnaround narrative gains traction.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is experiencing high volume and robust discussion following strong Q4 earnings, which showed accelerated sales of its flagship rare disease drug, MIPLYFFA. The market is re-evaluating ZVRA's potential as it transitions to a profitable commercial-stage company, with many in the community anticipating further upside ahead of potential European approval.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is a top trending stock ahead of its crucial earnings report, sparking a fierce debate among investors over whether its substantial AI infrastructure investments will fuel significant cloud growth or exacerbate concerns about its rising debt and negative free cash flow. Conflicting reports regarding data center expansion plans with OpenAI and potential layoffs have further amplified market volatility and option activity.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. (CITR) is gaining attention as its CEO presents at the iAccess Alpha conference, driving community interest in the low-float stock's fire-retardant technology, which traders believe has significant potential in the growing market for fire prevention materials.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending after being selected for a White House-backed air taxi program and launching Uber Air services in Dubai, marking significant strides toward commercialization, while a rival's countersuit alleging undisclosed foreign ties and potential fraud ignites active community discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down - What's Next?

Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down - Time to Sell...

After Golden Cross, Oric Pharmaceuticals, Inc. (ORIC)'s Technical Outlook is Bright

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Oric Pharmaceuticals, Inc. $ORIC Stake Raised by Royce & Associates LP

Royce & Associates LP raised its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 521.2% in the third quarter, according to its most recent 13F filing with the Securities and...

Oric Pharmaceuticals Teases Key 2026 Catalysts, Phase 3 Plans for Prostate and Lung Cancer Drugs

Executives from Oric Pharmaceuticals (NASDAQ:ORIC) used a conference discussion to highlight near-term clinical catalysts for its two lead oncology programs and to outline how upcoming data could...

Oric Pharmaceuticals (NASDAQ:ORIC) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Oric Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Oric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $702,520.00 in Stock

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) CFO Dominic Piscitelli sold 52,000 shares of the firm's stock in a transaction on Tuesday, February 24th. The shares were sold at an average...

Dominic Piscitelli Sells 52,000 Shares of Oric Pharmaceuticals (NASDAQ:ORIC) Stock

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) CFO Dominic Piscitelli sold 52,000 shares of Oric Pharmaceuticals stock in a transaction that occurred on Tuesday, February 24th. The shares...

Wall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to Trade

The mean of analysts' price targets for Oric Pharmaceuticals (ORIC) points to a 58.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Q1 EPS Forecast for Oric Pharmaceuticals Raised by Analyst

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) - HC Wainwright lifted their Q1 2026 earnings estimates for Oric Pharmaceuticals in a research note issued to investors on Tuesday, February...

Oric Pharmaceuticals (NASDAQ:ORIC) Trading 7.9% Higher Following Earnings Beat

Oric Pharmaceuticals (NASDAQ:ORIC) Trading 7.9% Higher on Strong Earnings...

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $ORCL earnings Tuesday?

ORIC
ORIC Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ORIC News

ORICORIC Pharmaceuticals Inc